June 11, 2020 / 4:46 AM / a month ago

BRIEF-Relief Therapeutics And NeuroRx Expand Trial Of RLF-100 In COVID-19 Patients

June 11 (Reuters) - RELIEF THERAPEUTICS HOLDING SA:

* RELIEF THERAPEUTICS AND NEURORX EXPAND CLINICAL TRIAL EVALUATING RLF-100 IN CRITICALLY ILL COVID-19 PATIENTS WITH RESPIRATORY FAILURE TO HOUSTON METHODIST HOSPITAL

* CLINICAL TRIAL TO ENROLL 144 PATIENTS TOTAL WITH EXPANSION TO ADDITIONAL SITES Source text: bit.ly/2MKzNEs Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below